Isolated chemotherapeutic perfusion of the pelvis for advanced rectal cancer

Colorectal Disease

Volumn 5, Issue 5, 2003, Pages 508-514

  Wanebo, Harold J ^a   Belliveau, J ^a   Begossi, G ^a   Levy, A ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Advanced malignancy; Chemotherapeutic perfusion; Rectal cancer

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; FLUOROURACIL; GRANULOCYTE COLONY STIMULATING FACTOR; MITOMYCIN C;

ADULT; ADVANCED CANCER; AGED; ANUS CANCER; ARTICLE; BALLOON CATHETER; CANCER PAIN; CANCER PALLIATIVE THERAPY; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG RESPONSE; FEMALE; HOSPITALIZATION; HUMAN; LENGTH OF STAY; MALE; NEUTROPENIA; PELVIS PAIN SYNDROME; PRIORITY JOURNAL; RECTUM CANCER; TUMOR REGRESSION;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BALLOON DILATATION; CHEMOTHERAPY, CANCER, REGIONAL PERFUSION; CISPLATIN; FEMALE; FLUOROURACIL; HUMANS; MALE; MIDDLE AGED; MITOMYCINS; PALLIATIVE CARE; PELVIS; PREOPERATIVE CARE; RECTAL NEOPLASMS; TREATMENT OUTCOME;

EID: 0042829278     PISSN: 14628910     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1463-1318.2003.00523.x     Document Type: Article

References (27)

1. Austen WA, Monaco AP, Richardson G et al. Treatments of malignant pelvic of tumors by extra corporeal perfusion with chemotherapeutic agents. N Engl J Med 1959; 261: 1037.
2. Watkins E Jr, Hering AC, Luna R, Adams HD. The use of intravascular balloon catheters for isolation of the pelvic bed during pump oxygenator perfusion of cancer chemotherapeutic agents. Surg Gynecol Obstet 1960; 111: 464-8.
3. Stehlin JS, Clark RL, White EC. Regional chemotherapy for cancer: experience with 116 perfusions. Ann Surg 1960; 151: 605.
4. Shingleton WW, Parker RT, Mahaley S. Abdominal perfusion for cancer chemotherapy with hypothermia and hyperthermia. Surgery 1961; 50: 260-5.
5. Lawrence W Jr, Juehn P, Mori S. Regional perfusion of the pelvis: considerations of the leakage problem. Surgery 1961; 50: 248-59.
6. Lawrence W Jr, Clarkson B, Kim M, Clapp P, Randall HT. Regional perfusion of pelvis and abdomen by an indirect technique. Cancer 1963; 16: 567.
7. Lathrop JC, Leone LA, Soderberg CH, Colbert MP, Vargas LL. Perfusion chemotherapy for gynecological malignancy. Trans N Engl Obstet Gynecol Soc 1963; 17: 47-56.
8. Miller DG, Lawrence W. Bone marrow protection in mechlorethamine (nitrogen mustard) therapy. Arch Surg 1962; 85: 430-41.
9. Wile A, Smolin M. Hyperthermic pelvic isolation-perfusion in the treatment of refractory pelvic cancer. Arch Surg 1987; 122: 1321-5.
10. Turk PS, Belliveau JF, Darnowski JW et al. Isolated pelvic perfusion for unresectable cancer using a balloon occlusion technique. Arch Surg 1993; 128: 533-9.
11. Hagstrom L, Jonsson PE, Landberg T et al. Intra-arterial infusion chemotherapy (5FU) in patients with inextirpable or locally recurrent rectal cancer. Am J Surg 1979; 173: 757-6.
12. Oberfield RA. (1983) Intra-arterial infusion in tumors of the pelvis. In: Recent Results in Cancer Research (eds. ), pp. 15-25. Springer-Verlag, Berlin.
13. Heim ME, Eberwein S, Georgi M. Palliative therapy of pelvis tumors by intra-arterial infusion of cytotoxic drug. In: Recent Results in Cancer Research. (eds. ), pp. 37-40. Springer-Verlag, Berlin.
14. Patt Y, Peters RE, Chuang VP et al. Palliation of pelvic recurrence of colorectal cancer with intra-arterial 5FU and mitomycin. Cancer 1985; 56: 2175-80.
15. Wright KC, Wallace S, Kim EE et al. Pulsed arterial perfusions: chemotherapeutic implications. Cancer 1986; 57: 192-6.
16. Carlsson C, Hafstrom L, Jonsson PE, Ask A, Kallum B, Lunderquist A. Unresectable and locally recurrent rectal cancer treated with radiotherapy or bilateral internal iliac artery infusion of 5FU. Cancer 1986; 58: 336-40.
17. Creech O, Krementz ET, Ryan R-F, Winblad JN. Chemotherapy of cancer; regional perfusion utilizing an extra corporeal circuit. Ann Surg 1959; 148: 616-32.
18. Keenan L, Turk PS, Vezeridis MP, Wanebo HJ. Isolated pelvic perfusion in a canine model: patient treatment considerations. Proc Am Soc Clin Oncol 1991; 10: 146.
19. Wanebo HJ, Chung MA, Levy AI, Turk PS, Vezeridis MP, Belliveau JF. Preoperative therapy for advanced pelvic malignancy by isolated pelvis perfusion with the balloon-occlusion technique. Anals Surg Oncol 3 Year?; 3: 295-303.
20. Muchmore JH, Kramentz ET, Carter RD, Preslan JE, George WI. Treatment of abdominal malignant neoplasms using regional chemotherapy with hemofiltraton. Arch Surg 1991; 126: 1390-6.
21. Nord LD, Stolfi RL, Martin DS. Biochemical modulation of 5-fluorouracil with leucovorin or delayed uridine rescue: correlation of anttitumor activity with dosage and Fura incorporation into RNA. Biochem Pharmacol 1992; 43: 2543-9.
22. Thom AK, Alexander Hr Andrich MP, Barker WC, Rosenberg SA, Fraker DL. Cytokine levels and systemic toxicity in patients undergoing isolated limb perfusion with high-dose tumor necrosis factor, interferon gamma, and melphalan. J Clin Oncol 1995; 13: 264-73.
23. Lejeune FJ, Lienard D, Leyvraz S et al. Regional chemotherapy of melanoma. Eur J Cancer 1993; 294: 606-12.
24. Hoekstra HJ, Naujocks T, Koops HS et al. Continuous leaking monitoring during hyperthermic isolated regional perfusion of the lower limb: techniques and results. Reg Cancer Treat 1992; 4: 301-4.
25. Dedrich RL. Arterial drug infusion: pharmacokinetic implications problems and pitfalls. Cancer JNCI 1986; 80: 84-9.
26. Sartorelli AC. Therapeutic attack of hypoxic cells of solid tumors: Presidential address. Cancer Res 1988; 48: 775-8.
27. Cavaliere R, Ciocatto BC, Giovanelli BC et al. Selective heat sensitivity of cancer cells. Cancer 1969; 20: 1351-81.